Cargando…

Pembrolizumab: First in Class for Treatment of Metastatic Melanoma

Detalles Bibliográficos
Autor principal: Barnhart, Carrie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625629/
https://www.ncbi.nlm.nih.gov/pubmed/26557410
_version_ 1782398009997262848
author Barnhart, Carrie
author_facet Barnhart, Carrie
author_sort Barnhart, Carrie
collection PubMed
description
format Online
Article
Text
id pubmed-4625629
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Harborside Press
record_format MEDLINE/PubMed
spelling pubmed-46256292015-11-09 Pembrolizumab: First in Class for Treatment of Metastatic Melanoma Barnhart, Carrie J Adv Pract Oncol Review Article Harborside Press 2015 2015-05-01 /pmc/articles/PMC4625629/ /pubmed/26557410 Text en Copyright © 2015, Harborside Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited and is for non-commercial purposes.
spellingShingle Review Article
Barnhart, Carrie
Pembrolizumab: First in Class for Treatment of Metastatic Melanoma
title Pembrolizumab: First in Class for Treatment of Metastatic Melanoma
title_full Pembrolizumab: First in Class for Treatment of Metastatic Melanoma
title_fullStr Pembrolizumab: First in Class for Treatment of Metastatic Melanoma
title_full_unstemmed Pembrolizumab: First in Class for Treatment of Metastatic Melanoma
title_short Pembrolizumab: First in Class for Treatment of Metastatic Melanoma
title_sort pembrolizumab: first in class for treatment of metastatic melanoma
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625629/
https://www.ncbi.nlm.nih.gov/pubmed/26557410
work_keys_str_mv AT barnhartcarrie pembrolizumabfirstinclassfortreatmentofmetastaticmelanoma